ISNTD Research Hub

Dengue VOICE highlights

dengue, VOICE

Workshop: Vector Borne Disease Toolkit with Dr Richard Allan (MENTOR Initiative)

Dr. Richard Allan CEO of the MENTOR Initiative conducts an interactive workshop at our July 2017 annual ISNTD Bites conference. Disease control toolsets are explored and then placed into context of field work moving away from the vertical approach to much more integrated approach. A must watch for all vector control, disease control, NGO and field agency specialists. Recorded at the annual ISNTD Bites conference on July 19th 2017 at the Institute of Child Health, London.

Petra Van-Sloun (Merck Performance Materials): Insect repellents & regulatory hurdles in the EU

At the annual ISNTD Bites conference, Petra Van Sloun from Merck Performance Materials speaks about current research and products at Merck for insect repellents, as well as the challenges posed by the regulatory framework in the EU for this field.

Pr. Gabriella Gibson (University of Greenwich): Vector behaviour & control and surveillance

At the annual ISNTD Bites conference on vector-borne diseases and vector control, Pr. Gabriella Gibson from the University of Greenwich speaks about the importance of understanding the behaviour of vectors to improve the control and surveillance of vectors. The presentation focuses on the tse-tse fly and mosquitoes. Recorded at ISNTD Bites 2017 on July 19th at the Institute of Child Health, London.

Dr. Julian Entwistle (IVCC): Challenges & innovation partnerships for vector control

At the ISNTD Bites 2017 conference, Dr. Julian Entwsitle from IVCC speaks about current partnerships and innovations in development at IVCC to tackle future challenges in vector control, including the development of future insecticides. Dr. Entwistle also lists some of the main gaps currently in vector control. Recorded on July 18th 2017 at the Institute of Child Health, London.

Dr. Waleed Al Salem (Ministry of Health Saudi Arabia): Controlling NTDs in Saudi Arabia

At ISNTD Bites 2017, Dr. Waleed Al-Salem speaks about the current landscape of prevalence and infection for NTDs in Saudi Arabia as well as the recent efforts to establish a Centre for NTDs in Saudi Arabia and for the Middle Eastern region.

Aaron Hoyles (Break Dengue): Global Health Networks & the Case for Integrated Dengue Programs

At the annual ISNTD Bites conference on vector control & NTDs, Aaron Hoyles from The Synergist speaks about current initiatives and platforms within the Break Dengue campaign to address surveillance, data and advocacy about dengue worldwide.

Andrew Wyborn (Greenmash): Improved performance management for NTD programs

At the annual ISNTD Bites conference on vector control, Andrew Wyborn (CEO at Greenmash) speaks about the impact of Greenmash's data management and project reporting systems and platform, Mango, on disease control programmes.

Dr. Richard Allan (The MENTOR Initiative): Vector control toolkit for leishmaniasis in Syria

At the annual ISNTD Bites conference on vector-borne diseases and vector control, Dr. Richard Allan, CEO at the MENTOR Initiative, speaks about the current extent of leishmaniasis in Syria, as well as the role of the MENTOR Initiative and its vector-control toolkit in adressing the disease outbreak as well as associated humanitarian needs.

Pr. James Logan (London School of Hygiene & Trop Med): Zika workshop

At the annual ISNTD Bites conference on vector-borne diseases and vector control, Pr. James Logan gives an overview of the zika virus and recent outbreak, as part of a Zika workshop. Please also view the related presentations from the zika workshop: • Anna Drexler (World Health Organisation): Vector control response to Zika: pathways for new tools • Hannah Kuper (LSHTM): Congenital Zika syndrome: What is it and how can we help? • Julian Entwistle (IVCC): Gaps in existing vector control programmes for Aedes Recorded at ISNTD Bites 2017 on July 19th 2017 at the Institute of Child Health, London.

Dr. Julian Entwistle (IVCC): Survey of gaps in vector-control (Zika workshop)

At the annual ISNTD Bites conference on vector-borne diseases and vector-control, Dr. Julian Entwistle from the IVCC speaks about IVCC's survey of capability gaps in Aedes aegypti control programs, as part of a workshop on Zika. Please also view the related presentations from the zika workshop: • Pr. James Logan (London School of Hygiene & Trop Med): Zika, an introduction • Anna Drexler (World Health Organisation): Vector control response to Zika: pathways for new tools • Hannah Kuper (LSHTM): Congenital Zika syndrome: What is it and how can we help? Recorded at ISNTD Bites 2017 on July 19th 2017 at the Institute of Child Health, London.

Dr. Hannah Kuper (LSHTM): Congenital Zika syndrome, what is it & how can we help?

At the annual ISNTD Bites conference on vector-borne diseases and vector control, Dr. Hannah Kuper, Director of the International Centre for Evidence in Disability at the London School of Hygiene & Tropical Medicine, gives an overview of Congenital Zika Syndrome and the impact this has on families worldwide in terms of infants' disability as well as opportunities for community support and advocacy. Please also view the related presentations from the zika workshop: • Pr. James Logan (London School of Hygiene & Trop Med): Zika, an introduction • Anna Drexler (World Health Organisation): Vector control response to Zika: pathways for new tools • Dr. Julian Entwistle (IVCC): Gaps in existing vector control programmes for Aedes Recorded at ISNTD Bites 2017 on July 19th 2017 at the Institute of Child Health, London.

Panel discussion: Zika workshop

At the annual ISNTD Bites conference on vector-borne diseases and vector control, panelists discuss the recent zika outbreak and response, across the whole spectrum from vector-control to patient support. Panelists: • James Logan (London School of Hygiene & Tropical Medicine) • Anna Drexler (World Health Organisation) • Hannah Kuper (LSHTM) • Julian Entwistle (IVCC) • Laura Appleby (Partnership for Child Development, Imperial College London) Chair: Marianne Comparet (ISNTD)

Anna Drexler (World Health Organisation): Vector control response to Zika - pathways for new tools

At the annual ISNTD Bites conference on vector-borne diseases & vector control, Dr. Anna Drexler from the WHO speaks about the current reposnse to zika outbreaks and the tools and collaborations which have been developed to address this public health threat. Recorded as part of the Zika Workshop at ISNTD Bites 2017 on July 19th at the Institute of Child Health, London.

Ailie Robinson (LSHTM): Influence of Plasmodium infection on human volatile odour

At the annual ISNTD Bites conference on vector-borne diseases and vector control, Ailie Robinson, from the London School of Hygiene & Tropical Medicine, speaks about recent research investigating the influence of Plasmodium infection on the human volatile odour profile in an endemic setting. Recorded at ISNTD Bites 2017 on July 19th at the Institute of Child Health, London.

Mark Carnegie-Brown (Oxitec): Advanced genetics & molecular biology for Aedes control

At the annual ISNTD Bites conference on vector-borne diseases and vector control, Mark Carnegie-Brown, CEO at Oxitec, speaks about the impact of Oxitec's genetic and molecular solutions on controlling populations of Aedes mosquitoes as well as Aedes-borne diseases. Recorded at ISNTD Bites 2017 on July 19th at the Institute of Child Health, London.

Paul Ready (Natural History Museum): Integrated control of leishmaniasis in Brazil

At the annual ISNTD Bites conference on vector-borne diseases and vector control, Paul Ready, from the Natural History Museum London and the LSHTM, speaks about the vector of leishmaniasis in Brazil and the changes posed in applying vector control as part of an integrated approach to disease control. Recorded at ISNTD Bites 2017 on July 19th at the Institute of Child Health, London.

Theresa Maier (Merck): Gene editing platform for snail control & schistosomiasis

At the annual ISNTD Bites 2017 conference on vector-borne diseases and vector control, Theresa Maier, from the University of Cambridge, speaks about current collaborative research with Merck on a gene editing platform to tackle snail control as part of the fight against schistosomiasis. Recorded at ISNTD Bites 2017, July 19th, at the Institute of Child Health, London.

Pr Russell Stothard (LSTM): Snail control to interrupt schistosome transmission in Cameroon

At the annual ISNTD Bites conference on vector-borne diseases and vector control, Pr. Russell Stothard from the Liverpool School of Tropical Medicine and the COUNTDOWN on NTDs consortium speaks about current research and initiatives in the areas of the crater lakes of Barombi Kotto and Mbo, Cameroon to control snail populations in order to reduce schistosome transmission. Recorded at ISNTD Bites 2017, July 19th, at the Institute of Child Health, London.

Panel discussion: Vector control and new partnerships for disease control

At the annual ISNTD Bites conference on vector-borne diseases and vector control, panelists discuss the challenges and opportunities arising from partnerships with the vector control community to tackle disease control. Panelists: • Dr. Julian Entwistle (IVCC) • Aaron Hoyles (Break Dengue) • Dr Waleed Al Salem (Ministry of Health Saudi Arabia) • chair: Marianne Comparet (ISNTD) Please also view the presentations of panelists above in the ISNTD Bites 2017 YouTube playlist. Recorded at ISNTD Bites 2017, July 19th, Institute of Child Health, London.

Panel discussion: Innovations & technology in vector control for global health

At the annual ISNTD Bites conference on vector-borne diseases and vector control, panelists discuss recent developments in vector control technology and the impact of these tools and innovation on vector control and disease control. • Panel discussion chair: Dr. Anna Drexler (World Health Organisation) • Panelists: Dr. Karina Mondragon-Shem (Liverpool School of Tropical Medicine) Dr. Richard Allan (The MENTOR Initiative) Andrew Wyborn (Greenmash) Petra Van-Sloun (Merck Performance Materials)

Panel discussion: Vector-borne diseases - disease focus

At the annual ISNTD Bites conference on vector-borne diseases and vector control, panelists highlight recent developments and research in vector-borne disease control. Panelists: • Theresa Maier (Merck) • Paul Ready (Natural History Museum) • Ailie Robinson (London School of Hygiene & Tropical Medicine) • Mark Carnegie-Brown (Oxitec) • chair: Pr Russell Stothard (Liverpool School of Tropical Medicine) Recorded at ISNTD Bites 2017, July 19th, Institute of Child Health, London.

ISNTD Interview: Dr. Dima El Safadi (Lebanese University)

The Syrian migration crisis, with over 1 million refugees now in Lebanon, has created a series of stresses and tensions in an already fragile public health infrastructure. Leishmaniasis is profiled within this migrant population and Dima El Safadi outlines a public health research framework that looks to tackle this issue from a variety of angles, epidemiology, diagnostics, vector control, community engagement. Dr. El Safadi also speaks candidly about the types of partnerships that are needed in order to drive this ambitious programme forward.

Panel discussion: Vaccines, NTDs & shaping the future for collaborative disease control

Recorded at the annual ISNTD D3 ( drug discovery , development and diagnostics ) meeting May 2017, the panel chaired by Clark Cole from the Access to Medicine Foundation discuss the potential impact of vaccines to NTD disease control - uncovering how the collaboration needs to be redefined. • Chairperson: Clarke Cole (Access to Medicine Foundation) • Dr. Ben Makepeace (University of Liverpool) • Dr. Valerie Oriol Mathieu (Janssen Vaccines & Prevention) • Enwono Eyoh (University of Edinburgh) • Dr. Judith Kallenberg (GAVI)

Panel discussion: Pipeline, platforms & current gaps in treatment for diseases of poverty

Pipeline & platforms Chair : Dr Duc H. Le ( Editor in Chief - EBio Medicine ) • Dr. Benny Baeten (J&J Global Health) • Dr. Ivan Scandale (DNDi) • Dr. Kelly Johnston (AWOL & Liverpool School of Tropical Medicine) • Angela Loyse ( St. George's, University of London)

Panel Discussion: Global Partnerships & Collaboration for NTD discovery & development

Recorded at the annual ISNTD D3 2017 2 day partnering meeting - Jaysree Iyer CEO of Access to Medicine Foundation chaired a panel focused on partnership and collaboration models needed to drive future drug discovery and development within the NTD space. The panel was made up of : • Chair: Jayasree Iyer (Access to Medicine Foundation) • Dr. Magda Moutaftsi (EDCTP) • Dr. Ivan Scandale (DNDi) • Dr. Paul Willis (MMV) • Dr. Valerie Oriol Mathieu (Janssen Vaccines & Prevention) • Dr. Kelly Johnston (LSTM) • Dr. Iain Gardiner (NHM) • Dr. Judith Kallenberg (GAVI) For more information please contact Kamran Rafiq Communications Director ISNTD email: krafiq:isntd.org

Panel discussion: New frontiers in diagnostic development: unmet needs and opportunities

Recorded at the annual ISNTD D3 ( drug discovery, development and diagnostics for NTDs ) 2017 meeting - panelists discuss the recent developments within diagnostics for NTDs and uncover the unmet needs likely to impact and shape future development. Funding, Evolution of PDP's, Data • Pr. Rosanna Peeling (London School of Hygiene & Tropical Medicine) • Dr. Laurence Flevaud (Médecins Sans Frontières) • Dr. Xavier Ding (FIND Diagnostics) • Dr. Ole Lagatie (Janssen Diagnostics)

Panel discussion: Technology & Data for Diagnostics in field: practicalities and challenges

Recorded at the annual ISNTD D3 ( discovery, development and diagnostics for NTDs) May 2017 - the panel debates the tech and data landscape from an enabling diagnostics perspective Panel: • Blaine Doyle (GlowDx) • Andrew Wyborn (Greenmash) • Dr. Harriet Glindon (i-sense)

Dr. Ben Makepeace TOVA: The whys, woes and weapons for immunising against river blindness

Dr Ben Makepeace speaks about River Blindness and the TOVA project at the annual ISNTD D3 conference May 2017

Panel discussion: Diagnostics for NTDs & diseases of poverty, innovation & solutions

Panelists discuss the latest innovations and solutions in diagnostics for NTDs, with a focus on current challenges and the roadmap for future disease control. Panelists: • Dr. Jim Mulry (Merck) • Dr. Simone Kann (Maximillian University Würzburg) • Dr. Bonnie Webster (Natural History Museum) • Dr. Rita Oliveira (Imperial College London) • Dr. Stephan Goetz (Iceni Diagnostics) Recorded at the ISNTD d³ 2017 conference on May 16-17th 2017 at the Wellcome Trust London.

Panel discussion: Technology & data for diagnostics in field, practicalities & challenges

Panelists discuss the role of technology & data for diagnostics of NTDs and diseases of poverty in field. Panelists: • Blaine Doyle (GlowDx) • Andrew Wyborn (Greenmash) • Dr. Harriet Glindon (i-sense) Recorded at the ISNTD d³ 2017 conference on May 16-17th 2017 at the Wellcome Trust London.

Panel discussion: Global partnerships & collaboration for discovery & development

Panelists discuss global partnerships and collaboration for drug discovery & development in neglected tropical diseases and disease of poverty. Chaired by Jayasree Iyer (Access to Medicine Foundation) Panelists: • Dr. Magda Moutaftsi (EDCTP) • Dr. Ivan Scandale (DNDi) • Dr. Paul Willis (MMV) • Dr. Valerie Oriol Mathieu (Janssen Vaccines & Prevention) • Dr. Kelly Johnston (Liverpool School Tropical Medicine) • Dr. Iain Gardiner (Natural History Museum) • Dr. Judith Kallenberg (GAVI) Recorded at the ISNTD d³ 2017 conference on May 16-17th 2017 at the Wellcome Trust London.

Panel discussion: vaccines, NTDs & shaping the future for collaborative disease control

AT ISNTD d³ 2017, panelists discuss NTD vaccines and the role of vaccines as part of a multifaceted approach to disease control, surveillance and elimination. Panelists include: • Chair: Clarke Cole (Access to Medicine Foundation) • Dr. Ben Makepeace (University of Liverpool) • Dr. Valerie Oriol Mathieu (Janssen Vaccines & Prevention) • Enwono Eyoh (University of Edinburgh) • Dr. Judith Kallenberg (GAVI)

Panel discussion: Current gaps & research priorities for NTD drug discovery

Panel discussion at ISNTD d³ 2017, chaired by Mr. Duc H. Le, Editor in Chief at EBio Medicine. Panelists are: • Dr. Benny Baeten (J&J Global Health) • Dr. Ivan Scandale (DNDi) • Dr. Kelly Johnston (AWOL & Liverpool School of Tropical Medicine) • Rachel Clare (AWOL & Liverpool School of Tropical Medicine) • Pr. David Sattelle (University College London) • Dr. Angela Loyse (St George's, University of London) • Dr Mallika Lavania (Stanley Browne Laboratories / The Leprosy Mission England & Wales)

Dr. Judith Kallenberg (GAVI): GAVI & accelerating access to vaccines for the developing world

Recorded at our annual ISNTD D3 - drug discovery, development and diagnostics conference - Judith Kallenberg talks about GAVI's take on challenges and opportunities in implementation, funding, market failure and partnerships in terms of accelerating access to vaccines for LMICs

Enwono Eyoh (University of Edinburgh): Why don't we have a vaccine for schistosomiasis?

At ISNTD d³ 2017, Enwono Eyoh, member of the Parasite Immuno-Epidemiology group at the University of Edinburgh, speaks about current research at Edinburgh on a schistosomiasis vaccine. Recorded at ISNTD d³ 2017, on May 16th 2017.

Pr. David Sattelle (University College London): The Search for New Drugs for Whipworm

At ISNTD d³ 2017, Pr. David Sattelle from University College London describes the current work at UCL to discover and develop new antihelminthic drugs for whipworm, a parasitic worm that infects 500 million people.

Dr. Benny Baeten (J&J Global Health): Solutions for Soil-Transmitted Helminths & Onchocerciasis

At ISNTD d³ 2017, Dr. Benny Baeten, Compound Development Team Leader Anthelmintics at Janssen Pharmaceutica (a J&J Global Health company) speaks about J&J's commitment to delivering the pledges of the 2012 London Declaration on NTDs, including current developments in antihelminthics research and partnerships.

Dr. Angela Loyse (St George's, Univ. of London): Cryptococcal Meningitis in LMICs

At ISNTD d³ 2017, Dr. Angela Loyse (St George's, University of London) speaks about the highly under-reported burden of cryptococcal meningitis in low & middle income countries, as well as the urgent gaps in access to effective treatment & diagnostic tests

ISNTD Interview: Dan Stuckey (EBioMedicine)

The ISNTD speaks to Dan Stuckey, Scientific Editor at EBioMedicine, about the journal's scope and impact for tropical disease research and publication. Recorded at ISNTD d³ 2017 at the Wellcome Trust on May 17th 2017.

ISNTD Interview: Dr. Ole Lagatie (Janssen Diagnostics)

The ISNTD catches up with Dr. Ole Lagatie, Senior Principal Research Scientist at Janssen Diagnostics, to discuss current research and tools at Janssen for NTD diagnostics, with a focus on onchocerciasis and soil-transmitted helminths diagnosis.

ISNTD Interview: Dr. Kelly Johnston (AWOL & Liverpool School of Tropical Medicine)

Dr. Kelly Johnston, from the A.WOL Consortium & Liverpool School of Tropical Medicine speaks to the ISNTD about the methodology and recent results from the A.WOL Consortium's work to find novel drugs against NTDs targeting the wolbachia bacteria in disease vectors. Recorded at ISNTD d³ 2017 on May 17th at the Wellcome Trust London.

ISNTD Interview: Dr. Simone Kann (Maximillian University Würzburg)

Dr. Simone Kann from the Maximillian University Würzburg speaks to the ISNTD about the highly underestimated global burden of Chagas disease, and the impact on diagnosis and monitoring of a new, high-specific Real-Time PCR from Dr. Kann's group at the University of Würzburg. Recorded at ISNTD d³ 2017 on May 17th 2017 at the Wellcome Trust London.

ISNTD Interview: Judith Kallenberg (GAVI)

Judith Kallenberg, Head of Policy at GAVI, speaks to the ISNTD about GAVI's role in driving access to vaccines globally as well as lessons for the NTD community. Recorded at the ISNTD d³ 2017 conference on May 17th 2017 at the Wellcome Trust London.

Panel discussion: Chagas R&D, funding and the path to public health policy

At ISNTD Chagas 2017, panelists explain and discuss funding mechanisms to advance R&D for Chagas disease, including the Priority Review Voucher system, the role of innovation in collaboration and reputation and the patent landscape. Chair: Kamran Rafiq (ISNTD) Pr. Jeffrey Moe (Duke University Global Health Institute) Dr. Cameron Durrant (KaloBios) Anne Marie Finley (Biotech Policy Group) www.isntdchagas.com

Dr Laurence Flevaud

Santiago Nicholls (PAHO): Chagas disease in the Americas

At ISNTD Chagas 2016, Santiago Nicholls, Infectious Diseases Advisor at the Pan American Health Organisation, gives a brief overview of Chagas disease in the Americas as well as PAHO's role in the control and advocacy of this diseases.

Panel discussion: Chagas disease - Epidemiology, Screening & Patient Advocacy

At ISNTD Chagas 2016, panelists discuss the challenges in the epidemiology and screening for Chagas disease as well as the opportunities for future collaborations for patient advocacy and disease control. Panelists include: Chair: Dr B.F Lee Hall (NIAID National Institutes of Health) Dr. Sheba Meymandi (Olive View UCLA Medical Centre) Ms. Malwina Carrion (ProMED, ISID) Dr. Yagahira Elizabeth Castro Sesquen (Johns Hopkins University) Dr. Monica Miranda Schaeubinger (John Hopkins University) Mr. Antonio Arce (Novartis)

Anne Marie Finley (Biotech Policy Group): Policy Options to Combat Chagas

At ISNTD Chagas, Anne Marie Finley (Biotech Policy Group) describes current policy options to combat Chagas disease, a growing public health issue, by sharing lessons from other diseases such as hepatitis C. ISNTD Chagas April 6th 2017 Washington DC www.isntdchagas.com

Cecilia Inés Centurión (Fundadora Todos Frente al Chagas): Chagas disease patent landscape

At the ISNTD Chagas conference, Cecilia Inés Centurión (Fundadora Todos Frente al Chagas/ Chagas Disease Alliance) speaks about the use of up-to- date technological information for decision-making in Chagas disease (this is a skype address), including an analysis of the patent landscape in Latin America for Chagas disease.

Dr. Cameron Durrant (KaloBios): Innovation in Reputation & Pricing to Bolster NTD Policy

At the ISNTD Chagas conference, Dr. Cameron Durrant (CEO at KaloBios) speaks about the role of innovation in reputation & pricing to bolster NTD policy, with special focus on KaloBios' novel approach and philosophy. ISNTD Chagas April 6th 2017 Washington DC www.isntdchagas.com

Pr. Peter Hotez (Baylor College & Sabin Vaccine Inst): Chagas Disease, NTDs & Blue Marble Health

At ISNTD Chagas, Pr. Peter Hotez speaks about the extent of the neglect for Chagas disease research and patient advocacy. Pr. Hotez also outlines the prevalence of Chagas disease in the US and worldwide, as well as the wider global health context.

paris

Dr. Henk Schallig (Academic Medical Centre): Molecular Diagnostics & Parasitic Diseases Elimination

Andrew Wyborn (Greenmash): Mobile Technology for Data Collection, Reporting & Programme Performance

At the ISNTD d³ conference on drug discovery & diagnostics for NTDs, Mr. Andrew Wyborn describes Greemash's MANGO system of data collection and dissemination and its applications to NTD and other programmes in the field.

David Urry (Natural History Museum): Parasites in Motion

At ISNTD Festival 2017, David Urry from the Natural History Museum London speaks about the museum's numerous events and initiatives to bring science from the scientists to the wider public. With input from Duncan Gregory and Anouk Gouvras, this presentation also focuses on a stop-motion animation about schistosomiasis as well as the scientists' and science communicators' collaborative roles.

James Arkinstall (DNDi): Sleeping Sickness Fundraising & Comms - Human Stories for New Audiences

At ISNTD Festival 2017, James Arkinstall, Head of Communications & Advocacy at DNDi, speaks about DNDi's efforts in sleeping sickness treatment and control with special focus on recent fundraising and awareness campaigns.

Roy Head (Development Media International): Evidence-based Behaviour Change Taken to Scale

At ISNTD Festival 2017, Roy Head, CEO at Development Media International (DMI), speaks about DMI's work in using mass media for health behaviour change with examples from leprosy campaigns (Brazil), trachoma campaigns (Ethiopia) and further health messages in Burkina Faso.

Claudia Cecalupo (Merck): Industry's contribution to corporate responsibility & global health

At ISNTD Festival 2017, Claudia Cecalupo from Merck speaks about Merck's commitment to the control of NTDs and diseases of poverty, with examples of engagement across film, cartoon, behaviour change programmes and collaborative drug discovery.

Yayne Hailu (The END Fund): Zimbabwe SMS Campaign - Mobilizing Communities via Mobile & Social Media

At the ISNTD Festival 2017, Yayne Hailu from the END Fund speaks about the impact and reach of a recent SMS & social media campaign on NTDs to reach communities across Zimbabwe.

John Gibb: Unfinished Business - Financing & Governance

At ISNTD Festival 2017, John Gibb speak about the challenges ahead for NTD control worldwide, including the role of effective governance on sustaining disease control, global health initiatives and securing financing.

Georgia Arnold (MTV Staying Alive Foundation): Storytelling to Impact Young Lives

At ISNTD Festival 2017, Georgia Arnold, Executive Director and Founder at MTV Staying Alive Foundation, speaks about the reach and impact of the MTV Shuga drama, as well as the role of the Foundation and mass media in encouraging positive behaviour change and health education amongst the youth.

Nicholas Brooke (Break Dengue): Building Data & Empowerment to Break Dengue

At ISNTD Festival 2017, Nicholas Brooke speaks about Break Dengue's current programmes and partnerships to improve the data- and technology-driven surveillance and control of dengue fever worldwide through numerous and varied partnerships globally.

Panel discussion: Impact of Corporate Philanthropy for NTDs & Global Health

This panel discusses, at the ISNTD Philanthropy 2014 conference the role and impact of corporate philanthropy in global health and NTDs. Panelists include: Ms. Sarah Marchal Murray (The END Fund); Dr. Edith Roset Bahmanyar (Novartis Foundation); Dr. Klaus Brill (Bayer Pharma); Ms. Sophia Wilkinson (BBC Media Action); Mr. Daniel Rostrup (Thomson Reuters Foundation); Ms. Martina Gliber (Findation Merieux). Chaired by Gill Sivyer (PwC).

Ignacio Willats (HackScience): HackScience - Bringing Research to the World Faster

At ISNTD Festival 2017, Ignacio Willats from Imperial College London presents the HackScience initiative, a Hackathon-led initiative to automate in a low-cost manner some of the most time-consuming lab-based tasks through innovation and collaboration.

Dr. Alfons Renz (University of Tubingen)

At ISNTD Festival 2017, Dr. Alfons Renz from the University of Tubingen speaks about long-term and collaborative research on onchocerciasis control, with a special focus on the communication of science & research, inclusion of patients and populations in endemic areas and the role of art.

Frederic Lohr (Mission Rabies): The Rabies App - Mobile Technology with a One Health Philosophy

At ISNTD Festival 2017, Frederic Lohr speaks about Mission Rabies' "Rabies App", enabling real-time tracking of rabies control programmes in the field, as well as its applicability to other diseases and programmes.

Pr. David Molyneux (LSTM): NTDs - the brand, the journey, the future

At ISNTD Festival 2017, Pr. David Molyneux, Professor Emeritus at the Liverpool School of Tropical Medicine speaks about the emergence and growth of Neglected Tropical Diseases as a concept and brand, as well as of the challenges ahead to sustain and accelerate the momentum in advocacy and disease control.

Edward Thomsen (LSTM): Games to Address Challenges in Tropical Health

At ISNTD Festival 2017, Edward Thomsen from the Liverpool School of tropical Medicine's ETCH Group (Engaging Tools for Communication in Health) speaks about the role of gaming in improving global health including specific examples of games developed by LSTM about insecticide resistance and HIV status.

Klaus Brill (Bayer): Bayer's Engagement in Fighting Neglected Tropical Diseases

At ISNTD Philanthropy, Dr. Klaus Brill from Bayer Pharma speaks about Bayer's commitment to the research and the treatment of neglected tropical diseases, with a focus on the role of corporate philanthropy in tackling diseases of poverty.

Thoko Pooley (Uniting to Combat NTDs)

At ISNTD Festival 2017, Thoko Pooley, Director of the Uniting to Combat NTDs Support Centre, speaks about the methodology, aims and artwork behind the creation of Uniting to Combat NTDs' Scorecard measuring progress in the control of NTDs.

Karen Batoosingh (Sanofi Pasteur): Dengue vaccine - challenges of pioneering a new model

At ISNTD Festival 2017, Karen Batoosingh, vice-president for dengue communications at Sanofi Pasteur, speaks about the current burden of dengue, Sanofi Pasteur's successful dengue vaccine and the broader challenges of developing sustainable new models for access to vaccines in developing countries.

Jaya Banerji (MMV): Pink for Science - creativity in malaria and science communications

At ISNTD Festival 2017, Jaya Banerji, Director of Communications & Advocacy at MMV, speaks about MMV's culture and strategies in terms of communication and branding of its messages in malaria, drug discovery and global health. Discover 'Pantone 220' and some of the benefits and challenges of using pink in science communication.

Matthew Warren (Oxitec): Genetically Engineered Mosquitoes and Community Engagement

At ISNTD Festival 2017, Matthew Warren speaks about Oxitec's strategies and channels to communicate important public health messages about genetically modified mosquitoes for disease control and ways to engage with the public on complex issues.

James Porter (The END Fund): The power of film: from funding to advocacy

At ISNTD Festival 2017, James Porter, Associate Director External Relations at the END Fund, speaks about the impact of film at The END Fund on fundraising, patients and the wider public with examples from NTD campaigns in Rwanda, Burundi and DRC.

Panel discussion: Communicating complex global health challenges

Chair: Andrew Jack (Financial Times) Lois Aspinall (BBC Media Action) Jaya Banerji (Medicines for Malaria Ventures) Karen Batoosingh (Sanofi Pasteur) Claudia Cecalupo (Merck) Thoko Pooley (Uniting to Combat NTDs) James Porter (The END Fund) Matthew Warren (Oxitec)

ISNTD Interview: Dan Mellor (Morever)

The ISNTD catches up with Dan Mellor from creative agency MOREVER at the ISNTD Festival 2017 to discuss the scope of Morever's communication and creative projects, including commissions for numerous partners in the field of global health such as the WHO, GHIT Fund and the Bill & Melinda Gates Foundation, as well as the important role of communication in raising awareness and advocacy for NTDs.

Lois Aspinall (BBC Media Action): Health communication highlights

At the ISNTD Festival 2017, Lois Aspinall from BBC Media Action speaks about strategies to communicate public health messages to a wide-ranging audience, and discusses several concrete examples.

ISNTD Interview: Lucy Casley (arctec / LSHTM)

At the ISNTD Festival 2017, we catch up with Lucy Casley from arctec, the arthropod and product testing centre based at the London School of Hygiene & Tropical Medicine. We speak about arctec's experience in vector control as well as in communicating important public health messages to scientists as well as the wider public.

ISNTD Interview: David Urry (Natural History Museum, London)

At the ISNTD Festival 2017, the ISNTD catches up with David Urry, Science Communicator at the Natural History Museum, London. David speaks about the NHM's successes in communicating scientific messages to a wide range of audiences as well as some of the main challenges faced as a Museum in this field.

ISNTD Festival 2017 SHOWREEL

A brief intro to our ISNTD Festival 2017! We bring together the creative industries and global health, with material and speakers across film, photo, comics, apps & gaming, mass media, design and marketing... with one common goal: advance the understanding and ultimately control of diseases of poverty! Discover further material at www.isntdfestival.com and on our YouTube "ISNTD Festival" playlist.

MTV Staying Alive Foundation: MTV Shuga "HIV Testing"

CIDEIM app for diagnosing cutaneous leishmaniasis

ISNTD Interview: Katie Greenland (London School of Hygiene & Trop Med)

Katie Greenland (LSHTM) speaks to Kamran Rafiq at the ISNTD Water conference about the role of formative research underpinning the design of behaviour change interventions for the “F” and “E” components of the SAFE strategy for trachoma control.

About SCI Video

ISNTD Interview: Donald Brooks (Initiative: Eau)

ISNTD Water: Technology Roundtable

Panel discussion at ISNTD Water 2016: WASH Technology & Innovation for NTDs and global health. Chair & panelists: Mariska Ronteltap (UNESCO-IHE); Donald Brooks (Initiative: Eau); ; Petra Wadstrom (Solvatten); John Mullett (Butyl Products); Alison Parker (Cranfield University).

Donald Brooks (Initiative: Eau): Water quality surveillance in developing urban centres

Donald Brooks, CEO & Founder at Initiative: Eau speaks at ISNTD Water 2016 about the WASHMobile innovation & technology and its impact on water quality surveillance in developing urban centres.

Lepra 1080P V3

Kilinochchi2015 011

Jaffna Jan2015 142

DNDi Drug Booster (ISNTD Film Festival)

DNDi Mycetoma (ISNTD Film Festival)

ENNAID 2 PRES

ISNTD Interview: Dr. Henk Schallig (Academic Medical Centre, Netherlands)

Dr. Henk Schallig speaks about current research and challenges in neglected disease diagnostics (with focus on malaria & leishmaniasis).

ISNTD interview: • Dr. Ahmed Abd El Wahed (Georg-August University Goettingen / TwistDx)

Dr. Abd El Wahed speaks to the ISNTD at ISNTD d³ 2016 about the current needs and challenges of disease diagnostics in the field and introduces the mobile suitcase laboratory for point of need rapid detection of Leishmania donovani using recombinase polymerase amplification assay.

ISNTD Interview: Dr. Mark Paine (Liverpool School of Tropical Medicine)

Dr. Mark Paine speaks to the ISNTD about research at LSTM to develop field diagnostics for insecticides and resistance.

ISNTD interview: Dr. Katy Graef (BIO Ventures for Global Health, BVGH)

Dr. Katy Graef speaks to the ISNTD about the objectives of BVGH and the consortium's role in catalysing collaborations to accelerate product development for NTDs and malaria.

Katie Greenland (LSHTM): Formative Research for behaviour change strategies

Katie Greenland from the London School of Hygiene & Tropical Medicine speaks at ISNTD Water 2016 (April 29th 2016) about the scope and methodology of formative research to improve and inform on behaviour change and trachoma control interventions, focusing on work in Ethiopia.

Dr. Paul Willis (MMV): Open source drug discovery & the MMV Pathogen Box

Dr. Paul Willis speaks at ISNTD d³ 2016 about Medicines for Malaria Venture's (MMV) Pathogen Box and its role in accelerating collaborative and open source drug discovery for malaria and tropical diseases.

Stacie June (Unilever): Super School of 5, hand & face washing intervention

Unilever's Stacie June speaks at ISNTD Water 2016 about Unilever & Sightsavers' joint programme to tackle face and hand washing and behaviour change among school children: The Super School of Five, a public private partnership on hand & face washing intervention.

Panel discussion - Open source: models for collaboration

Panel discussion at ISNTD d³ 2016 chaired by Katy Graef (BVGH). Panelists discuss current challenges and opportunities of an open source collaborative approach to tropical diseases drug discovery. Panelists: Dr. David Andrews (AstraZeneca); Dr. Raymond Hui (Structural Genomics Consortium); Tale Sliedrecht (European Lead Factory); Dr. Paul Willis (Medicines for Malaria Ventures, MMV).